RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Geou-Yarh Liou to Pancreatic Neoplasms

This is a "connection" page, showing publications Geou-Yarh Liou has written about Pancreatic Neoplasms.
Connection Strength

4.413
  1. Liou GY, Byrd CJ, Storz P, Messex JK. Cytokine CCL9 Mediates Oncogenic KRAS-Induced Pancreatic Acinar-to-Ductal Metaplasia by Promoting Reactive Oxygen Species and Metalloproteinases. Int J Mol Sci. 2024 Apr 26; 25(9).
    View in: PubMed
    Score: 0.848
  2. Liou GY. Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers. J Immunol Res. 2017; 2017:7979637.
    View in: PubMed
    Score: 0.545
  3. Liou GY, Bastea L, Fleming A, D?ppler H, Edenfield BH, Dawson DW, Zhang L, Bardeesy N, Storz P. The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis. Cell Rep. 2017 05 16; 19(7):1322-1333.
    View in: PubMed
    Score: 0.524
  4. Liou GY, Storz P. Protein kinase D enzymes: novel kinase targets in pancreatic cancer. Expert Rev Gastroenterol Hepatol. 2015; 9(9):1143-6.
    View in: PubMed
    Score: 0.461
  5. Liou GY, D?ppler H, Braun UB, Panayiotou R, Scotti Buzhardt M, Radisky DC, Crawford HC, Fields AP, Murray NR, Wang QJ, Leitges M, Storz P. Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia. Nat Commun. 2015 Feb 20; 6:6200.
    View in: PubMed
    Score: 0.449
  6. Liou GY, Leitges M, Storz P. Pancreatic oncogenic signaling cascades converge at Protein Kinase D1. Cell Cycle. 2015; 14(10):1489-90.
    View in: PubMed
    Score: 0.444
  7. Liou GY, D?ppler H, Necela B, Edenfield B, Zhang L, Dawson DW, Storz P. Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. Cancer Discov. 2015 Jan; 5(1):52-63.
    View in: PubMed
    Score: 0.439
  8. Bastea LI, Liou GY, Pandey V, Fleming AK, von Roemeling CA, Doeppler H, Li Z, Qiu Y, Edenfield B, Copland JA, Tun HW, Storz P. Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions. Cancer Res. 2019 04 01; 79(7):1535-1548.
    View in: PubMed
    Score: 0.147
  9. Ding L, Liou GY, Schmitt DM, Storz P, Zhang JS, Billadeau DD. Glycogen synthase kinase-3? ablation limits pancreatitis-induced acinar-to-ductal metaplasia. J Pathol. 2017 09; 243(1):65-77.
    View in: PubMed
    Score: 0.133
  10. Liou GY, D?ppler H, DelGiorno KE, Zhang L, Leitges M, Crawford HC, Murphy MP, Storz P. Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions. Cell Rep. 2016 Mar 15; 14(10):2325-36.
    View in: PubMed
    Score: 0.120
  11. Chen NM, Singh G, Koenig A, Liou GY, Storz P, Zhang JS, Regul L, Nagarajan S, K?hnemuth B, Johnsen SA, Hebrok M, Siveke J, Billadeau DD, Ellenrieder V, Hessmann E. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas. Gastroenterology. 2015 May; 148(5):1024-1034.e9.
    View in: PubMed
    Score: 0.112
  12. D?ppler H, Liou GY, Storz P. Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity. PLoS One. 2013; 8(1):e53676.
    View in: PubMed
    Score: 0.097
  13. Ardito CM, Gr?ner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK, Delgiorno KE, Carpenter ES, Halbrook CJ, Hall JC, Pal D, Briel T, Herner A, Trajkovic-Arsic M, Sipos B, Liou GY, Storz P, Murray NR, Threadgill DW, Sibilia M, Washington MK, Wilson CL, Schmid RM, Raines EW, Crawford HC, Siveke JT. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell. 2012 Sep 11; 22(3):304-17.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support